Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: An unexpected prognostic significance?

Neuropathology

Volumn 31, Issue 2, 2011, Pages 129-134

  Kren, Leos ^a   Slaby, Ondrej ^d   Muckova, Katarina ^a   Lzicarova, Eva ^e   Sova, Marek ^b   Vybihal, Vaclav ^b   Svoboda, Tomas ^b   Fadrus, Pavel ^b   Lakomy, Radek ^d   Vanhara, Petr ^f   Krenova, Zdenka ^c   Sterba, Jaroslav ^c   Smrcka, Martin ^b   Michalek, Jaroslav ^f  

^a Departments of Pathology   (Czech Republic)

^b Neurosurgery ^*  (Czech Republic)

^c UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^d Departments of Compreghensive Cancer Care   (Czech Republic)

^e MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^f MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Glioblastoma; HLA E; HLA G; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; HLA E ANTIGEN; HLA G ANTIGEN; TEMOZOLOMIDE;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TREATMENT RESPONSE;

BRAIN NEOPLASMS; CELL LINE, TUMOR; GLIOBLASTOMA; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952729102     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2010.01149.x     Document Type: Article

References (29)

1. Kovats S, Main EK, Librach C etal. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248: 220-223.
2. King A, Allan DS, Bowen M etal. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol 2000; 30: 1623-1631.
3. Carosella ED, Moreau P, Le Maoult J etal. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003; 81: 199-252.
4. Coupel S, Moreau A, Hamidou M etal. Expression and repase of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 2007; 109: 2806-2814.
5. Malmberg KJ, Levitsky V, Norell H etal. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD 94/NKG2A-dependent mechanism. J Clin Invest 2002; 110: 1515-1523.
6. Marin R, Ruiz-Cabello F, Pedrinaci S etal. Analysis of HLA-E expression in human tumors. Immunogenetics 2003; 54: 767-775.
7. Derre L, Corvaisier M, Charreau B etal. Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells. J Immunol 2006; 177: 3100-3107.
8. Bianchini M, Levy E, Zucchini C etal. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa. Int J Oncol 2006; 29: 83-94.
9. Wiendl H, Mitsdoerffer M, Hofmeister V etal. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol 2002; 168: 4772-4780.
10. Mittelbronn M, Simon P, Loffler C etal. Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells. J Neuroimmunol 2007; 189: 50-58.
11. Wischhusen J, Friese MA, Mittelbronn M etal. HLA-E protects glioma cells from NKG2D-mediated immune response in vitro: implications for immune escape in vivo. J Neuropathol Exp Neurol 2006; 64: 523-528.
12. Yie SM, Yang H, Ye SR etal. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Ann Surg Oncol 2007; 14: 2721-2729.
13. Ye SR, Yang H, Li K etal. Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol 2007; 20: 375-383.
14. Yie SM, Yang H, Ye SR etal. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Lung Cancer 2007; 58: 267-274.
15. Yie SM, Yang H, Ye SR etal. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am J Clin Pathol 2007; 128: 1002-1009.
16. Cai MY, Xu YF, Qiu SJ etal. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clin Cancer Res 2009; 15: 4686-4693.
17. Jung YW, Kim YT, Kim SW etal. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer. Reprod Sci 2009; 16: 1103-1111.
18. Bijen CB, Bantema-Joppe EJ, de Jong RA etal. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer. Int J Cancer 2010; 126: 1417-1427.
19. He X, Dong DD, Yie SM etal. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro. Ann Surg Oncol 2010; 17: 1459-1469.
20. Kleinberg L, Flørenes VA, Skrede M etal. Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma. Virchows Arch 2006; 449: 31-39.
21. Nückel H, Rebmann V, Dürig J etal. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 2005; 105: 1694-1698.
22. Levy EM, Bianchini M, Von Euw EM etal. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer. Int J Oncol 2008; 32: 633-641.
23. Perez-Chacon G, Rosado S, Rebolleda N etal. Prognostic irrelevance of HLA-G in B-cell chronic lymphocytic leukemia. Int J Lab Hematol 2009; 31: 327-337.
24. Lin A, Zhu CC, Chen HX etal. Clinical relevance and functional implications for human leukocyte antigen-G expression in non-small-cell lung cancer. J Cell Mol Med 2009. [Epub ahead of print: PMID: 19602033].
25. Suzuki H, Higuchi M, Hasegawa T etal. Tissue array analysis of the aberrant expression of HLA class I molecules in human non small cell lung cancer. Gan To Kagaku Ryoho 2006; 33: 1713-1716.
26. Ishigami S, Natsugoe S, Miyazono F etal. HLA-G expression in gastric cancer. Anticancer Res 2006; 26: 2467-2472.
27. Michelin S, Gallegos CE, Dubner D etal. Ionizing radiation modulates the surface expression of human leukocyte antigen-G in a human melanoma cell line. Hum Immunol 2009; 70: 1010-1015.
28. Urosevic M, Kempf W, Zagrodnik B etal. HLA-G expression in basal cell carcinomas of the skin recurring after radiotherapy. Clin Exp Dermatol 2005; 30: 422-425.
29. Davidson B, Elstrand MB, McMaster MT etal. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma. Gynecol Oncol 2005; 96: 42-47.